About the company
Partex markets an AI-powered platform focused on drug discovery and development, positioning the product around speeding up therapeutic asset identification and licensing decisions. The company highlights large-scale clinical-development and real-world data context and sells an “Asset Exchange” style workflow for iterative matching. Public-facing materials emphasise life sciences use cases and partnerships, including a recent pilot collaboration post with Bayer. Partex also presents itself as a multi-discipline group spanning AI, data, and life sciences.